RecruitingPhase 3NCT07037433
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Sponsor: Amgen
Mt. Pleasant, SC · +139 more sites
2 recruiting obesity studies with a site in Mt. Pleasant, SC.
Sponsor: Amgen
Mt. Pleasant, SC · +139 more sites
Sponsor: Eli Lilly and Company
Greenville, SC · Mt. Pleasant, SC · +39 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.